{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:07:17Z","timestamp":1784408837902,"version":"3.55.0"},"reference-count":26,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Denosumab is a frequently used medication, mainly for the treatment of osteoporosis and prevention of skeletal-related events in patients with metastatic cancer. However, the treatment can be associated with adverse events including hypocalcemia.<\/jats:p>\n               <jats:p>We discuss the therapeutic challenges of denosumab-induced hypocalcemia in a patient with metastatic prostate adenocarcinoma. This 87-year-old patient presented to the emergency department after being found on the floor with altered mental status. Denosumab had been initiated 3 weeks earlier for stage 4 prostate adenocarcinoma with osteoblastic bone metastatic lesions. Blood analyses showed severe hypocalcemia (3.89\u2005mg\/dL [0.97\u2005mmol\/L]), which did not improve despite progressive incremental parenteral calcium administration and cholecalciferol supplementation. Management required 64 days of admission and titration of calcitriol. The patient was discharged after stabilizing plasma calcium level. Outpatient palliative care was later initiated because of progressive prostate adenocarcinoma, which ultimately led to the patient's death. Patients with metastatic bone disease, especially when treated with denosumab for prevention of skeletal-related events, present an increased risk of severe and even refractory hypocalcemia. More data are needed for optimal risk stratification of these patients, to identify robust predictors of hypocalcemia and to define the appropriate timing for starting calcium and vitamin D supplementation in high-risk individuals.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf121","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T17:11:59Z","timestamp":1749834719000},"source":"Crossref","is-referenced-by-count":2,"title":["Refractory Denosumab-induced Hypocalcemia in a High-risk Patient With Osteoblastic Metastatic Prostate Adenocarcinoma"],"prefix":"10.1210","volume":"3","author":[{"given":"Jean Damascene","family":"Nizeyimana","sequence":"first","affiliation":[{"name":"Department of Geriatric Medicine, Universitair Ziekenhuis Brussel (UZ Brussel) , Laarbeeklaan 101, 1090 Jette, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Dreessen","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Universitair Ziekenhuis Brussel (UZ Brussel) , Laarbeeklaan 101, 1090 Jette, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Andreescu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB) , Laarbeeklaan 101, 1090 Jette, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan","family":"Duhamel","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Universitair Ziekenhuis Brussel (UZ Brussel) , Laarbeeklaan 101, 1090 Jette, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Lieten","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Universitair Ziekenhuis Brussel (UZ Brussel) , Laarbeeklaan 101, 1090 Jette, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4445-308X","authenticated-orcid":false,"given":"Eric","family":"Balti","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB) , Laarbeeklaan 101, 1090 Jette, Brussels ,","place":["Belgium"]},{"name":"Osteoporosis and Metabolic Bone Diseases Clinic, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB) , Laarbeeklaan 101, 1090 Jette, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"2025061313115031900_luaf121-B1","first-page":"20-0222","article-title":"Unusual hypocalcaemia in breast cancer relapse with multiple bone metastasis","volume":"2022","author":"Darawshi","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"4","key":"2025061313115031900_luaf121-B2","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/j.pbj.0000000000000045","article-title":"Hypocalcemia in cancer patients: an exploratory study","volume":"4","author":"Ferraz Gon\u00e7alves","year":"2019","journal-title":"Porto Biomed J"},{"issue":"1","key":"2025061313115031900_luaf121-B3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12885-024-11942-2","article-title":"Denosumab-induced hypocalcemia in patients with solid tumors and renal dysfunction: a multicenter, retrospective, observational study","volume":"24","author":"Nakamura","year":"2024","journal-title":"BMC Cancer"},{"issue":"26","key":"2025061313115031900_luaf121-B4","doi-asserted-by":"crossref","first-page":"e29731","DOI":"10.1097\/MD.0000000000029731","article-title":"Severe and refractory hypocalcaemia secondary to osteoblastic bone metastases in bladder signet ring carcinoma: a case report and literature review","volume":"101","author":"Zeng","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2025061313115031900_luaf121-B5","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.clgc.2014.11.008","article-title":"Severe hypocalcemia associated with denosumab in metastatic castration-resistant prostate cancer: risk factors and precautions for treating physicians","volume":"13","author":"Autio","year":"2015","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"2025061313115031900_luaf121-B6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s43441-024-00712-8","article-title":"Hypocalcemia event associated with denosumab: a real-world study from FDA Adverse Event Reporting System (FAERS) database","volume":"59","author":"Gao","year":"2025","journal-title":"Ther Innov Regul Sci"},{"key":"2025061313115031900_luaf121-B7","doi-asserted-by":"crossref","first-page":"1194718","DOI":"10.3389\/fonc.2023.1194718","article-title":"The prognostic value of Eastern Cooperative Oncology Group performance status on overall survival among patients with metastatic prostate cancer: a systematic review and meta-analysis","volume":"13","author":"Assayag","year":"2023","journal-title":"Front Oncol"},{"issue":"2","key":"2025061313115031900_luaf121-B8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","article-title":"The cachexia score (CASCO): a new tool for staging cachectic cancer patients","volume":"2","author":"Argil\u00e9s","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025061313115031900_luaf121-B9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"Dyba","year":"2021","journal-title":"Eur J Cancer"},{"issue":"7","key":"2025061313115031900_luaf121-B10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.21037\/atm.2020.03.55","article-title":"Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study","volume":"8","author":"Huang","year":"2020","journal-title":"Ann Transl Med"},{"issue":"1","key":"2025061313115031900_luaf121-B11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/pcan.2008.10","article-title":"Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease","volume":"12","author":"Tucci","year":"2009","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"2025061313115031900_luaf121-B12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2796.1989.tb01423.x","article-title":"The clinical spectrum of hypocalcaemia associated with bone metastases","volume":"226","author":"Riancho","year":"1989","journal-title":"J Intern Med"},{"issue":"8","key":"2025061313115031900_luaf121-B13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41571-021-00499-9","article-title":"Novel approaches to target the microenvironment of bone metastasis","volume":"18","author":"Hofbauer","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"2025061313115031900_luaf121-B14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study","volume":"19","author":"Raje","year":"2018","journal-title":"Lancet Oncol"},{"issue":"12","key":"2025061313115031900_luaf121-B15","first-page":"CD013020","article-title":"Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis","volume":"2020","author":"Jakob","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2025061313115031900_luaf121-B16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/cen.14169","article-title":"Hypocalcaemia following denosumab in prostate cancer: a clinical review","volume":"92","author":"Lau","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025061313115031900_luaf121-B17","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2147\/TCRM.S123172","article-title":"High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis","volume":"12","author":"Ishikawa","year":"2016","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"2025061313115031900_luaf121-B18","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1210\/clinem\/dgae290","article-title":"Vitamin D for the prevention of disease: an endocrine society clinical practice guideline","volume":"109","author":"Demay","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025061313115031900_luaf121-B19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/pros.20917","article-title":"Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid","volume":"69","author":"Lein","year":"2009","journal-title":"Prostate"},{"issue":"1","key":"2025061313115031900_luaf121-B20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41598-020-80243-y","article-title":"Predictors for development of denosumab-induced hypocalcaemia in cancer patients with bone metastases determined by ordered logistic regression analysis","volume":"11","author":"Kanbayashi","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"2025061313115031900_luaf121-B21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1148\/radiol.2021203783","article-title":"Development and validation of a radiomics model for differentiating bone islands and osteoblastic bone metastases at abdominal CT","volume":"299","author":"Hong","year":"2021","journal-title":"Radiology"},{"key":"2025061313115031900_luaf121-B22","doi-asserted-by":"crossref","first-page":"100653","DOI":"10.1016\/j.jbo.2024.100653","article-title":"Radiomics analysis of thoracic vertebral bone marrow microenvironment changes before bone metastasis of breast cancer based on chest CT","volume":"50","author":"Hao-Nan","year":"2025","journal-title":"J Bone Oncol"},{"issue":"1","key":"2025061313115031900_luaf121-B23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ctrv.2012.07.002","article-title":"Denosumab in patients with cancer and skeletal metastases: a systemic review and meta-analysis","volume":"39","author":"Peddi","year":"2012","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"2025061313115031900_luaf121-B24","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/j.2040-4603.2021.tb00173.x","article-title":"Intestinal calcium absorption","volume":"11","author":"Wongdee","year":"2021","journal-title":"Compr Physiol"},{"issue":"8","key":"2025061313115031900_luaf121-B25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41581-024-00835-z","article-title":"Calcium signalling and transport in the kidney","volume":"20","author":"Staruschenko","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"2025061313115031900_luaf121-B26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ndt\/gfae204","article-title":"Biology of calcium homeostasis regulation in intestine and kidney","volume":"40","author":"Deluque","year":"2025","journal-title":"Nephrol Dial Transplant"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/8\/luaf121\/63485675\/luaf121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/8\/luaf121\/63485675\/luaf121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T17:12:03Z","timestamp":1749834723000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf121\/8161747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,6,13]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf121","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,6,13]]},"article-number":"luaf121"}}